Loading…
Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $1.1B | $-65M | $-95M | $40M | -29.4% | -21.6% | 551.6% |
| 2024 | $1.3B | $4M | $-15M | $111M | -3.5% | -33.5% | -120.0% |
| 2023 | $2.0B | $129M | $73M | $235M | 15.5% | -28.0% | -60.9% |
| 2022 | $2.8B | $280M | $186M | $125M | 40.7% | - | - |
| 2021 |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 2,803.38 | 2,019.73 | 1,344 | 1,054.29 |
| Operating Revenue | - | 2,803.38 | 2,019.73 | 1,344 | 1,054.29 |
| Cost Of Revenue | - | 2,178.92 | 1,569.32 | 1,069.75 | 840.72 |
| Gross Profit | - | 624.46 | 450.41 | 274.25 | 213.57 |
| Operating Expense | 226.21 | - | 318.68 | - | - |
| Selling General And Administration | - | 324.21 | 300.33 | 233.38 | 200.68 |
| Total Expenses | - | 2,515.71 | 1,888 | 1,321.33 | 1,058.20 |
| Operating Income | - | 287.67 | 131.73 | 22.68 | -3.90 |
| Total Operating Income As Reported | - | 269.88 | 112.71 | -16.86 | -84.41 |
| EBITDA | - | 280.06 | 129.34 | 3.99 | -64.50 |
| Normalized EBITDA | - | 301.58 | 150.08 | 43.53 | 16.01 |
| EBIT | - | 267.49 | 110.99 | -14.21 | -81.29 |
| Interest Income | - | 0.01 | 0.08 | 2.05 | 3.13 |
| Interest Expense | - | 14.39 | 8.09 | 2.19 | 2.22 |
| Net Interest Income | - | -14.38 | -8.01 | -0.14 | 0.91 |
| Other Non Operating Income Expenses | - | 1.33 | -0.08 | 0.60 | -0.01 |
| Other Income Expense | - | -20.20 | -20.83 | -38.94 | -80.52 |
| Interest Income Non Operating | - | 0.01 | 0.08 | 2.05 | 3.13 |
| Interest Expense Non Operating | - | 14.39 | 8.09 | 2.19 | 2.22 |
| Net Non Operating Interest Income Expense | - | -14.38 | -8.01 | -0.14 | 0.91 |
| Pretax Income | - | 253.10 | 102.89 | -16.40 | -83.51 |
| Tax Provision | - | 67.11 | 30.26 | -1.84 | 11.34 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -5.70 | -6.10 | -4.44 | -16.91 |
| Net Income Continuous Operations | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Net Income From Continuing And Discontinued Operation | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Net Income From Continuing Operation Net Minority Interest | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Net Income | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Net Income Common Stockholders | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Net Income Including Noncontrolling Interests | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Normalized Income | - | 201.80 | 87.27 | 20.54 | -31.25 |
| Diluted NI Availto Com Stockholders | - | 185.98 | 72.63 | -14.56 | -94.85 |
| Basic Average Shares | - | 37.01 | 35.16 | 33.38 | 32.41 |
| Diluted Average Shares | - | 37.54 | 35.48 | 33.38 | 32.41 |
| Reconciled Depreciation | - | 12.58 | 18.35 | 18.20 | 16.79 |
| Reconciled Cost Of Revenue | - | 2,178.92 | 1,569.32 | 1,069.75 | 840.72 |
| Total Unusual Items | -9.48 | - | -20.74 | - | - |
| Total Unusual Items Excluding Goodwill | - | -21.52 | -20.74 | -39.54 | -80.51 |
| Minority Interests | 0 | 0 | - | - | - |
| Special Income Charges | - | -21.52 | -20.74 | -39.54 | -80.51 |
| Other Special Charges | - | 3.73 | 2.85 | 6.67 | 2.75 |
| Write Off | - | 9.61 | 14.56 | 21.43 | -0.44 |
| Impairment Of Capital Assets | - | 5.60 | 0.72 | 2.89 | 77.85 |
| Restructuring And Mergern Acquisition | - | 2.59 | 2.61 | 8.55 | 0.35 |
| Depreciation Amortization Depletion Income Statement | - | 12.58 | 18.35 | 18.20 | 16.79 |
| Depreciation And Amortization In Income Statement | - | 12.58 | 18.35 | 18.20 | 16.79 |
| Provision For Doubtful Accounts | - | 9.61 | 14.56 | 21.43 | - |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Cross Country Healthcare, Inc.this co. | CCRN | $409M | -4.31 | 1.27 | -29.4% | -4.69 |
| ClearPoint Neuro, Inc. | CLPT | $429M | -16.81 | 15.33 | -91.1% | -21.18 |
| Orthofix Medical Inc. | OFIX | $418M | -4.53 | 0.93 | -20.5% | 51.78 |
| Upstream Bio, Inc. | UPB | $404M | -2.82 | 1.19 | -42.2% | -1.90 |
| AirSculpt Technologies, Inc. | AIRS |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| $403M |
| -34.53 |
| 4.59 |
| -13.3% |
| 391.43 |
| Monopar Therapeutics Inc. | MNPR | $399M | -29.11 | 2.90 | -10.0% | -20.21 |
| Community Health Systems, Inc. | CYH | $393M | 0.77 | -0.28 | -36.5% | 5.53 |
| TruBridge, Inc. | TBRG | $391M | 89.74 | 2.20 | 2.4% | 12.54 |
| OmniAb, Inc. | OABI | $386M | -5.95 | 1.44 | -24.3% | -8.06 |
| Peer Median | - | -5.24 | 1.82 | -22.4% | 1.81 | |